1
A Study of Alendronate Sodium Vitamin D3 Tablets on Knee Osteoarthritis
Condition(s):Knee OsteoarthritisLast Updated:April 22, 2022Recruiting
Alendronate Sodium, AREA[OverallStatus], Open or Pending: 18 Clinical Trials, Page 1 of 2
Include Studies Not Open or Pending
2
64 Cu-DOTA-alendronate PET Imaging in Localizing and Characterizing Breast Calcifications in Participants Before Undergoing Mastectomy
Condition(s):Breast Carcinoma; CalcificationLast Updated:February 17, 2022Recruiting
3
Alendronate in an Weekly Effervescent Tablet Formulation Following Denosumab Discontinuation
Condition(s):Postmenopausal OsteoporosisLast Updated:March 16, 2022Recruiting
4
Effect of Alendronate 70mg Formulation on Bone Turnover Markers and Patient Reported Outcomes
Condition(s):Osteoporosis, PostmenopausalLast Updated:December 3, 2020Recruiting
5
A Phase III Clinical Study of Minodronate Tablets in Postmenopausal Women With Osteoporosis
Condition(s):OsteoporosisLast Updated:March 31, 2022Not yet recruiting
6
Comparative Antiresorptive Efficacy Discontinuation of Denosumab
Condition(s):Osteoporosis, Postmenopausal; OsteoporosisLast Updated:April 21, 2021Recruiting
7
The Optimal Sequential Therapy After Long Term Denosumab Treatment
Condition(s):OsteoporosisLast Updated:October 25, 2021Recruiting
8
Bisphosphonates for Prevention of Post-Denosumab Bone Loss
Condition(s):IOP; OsteoporosisLast Updated:January 26, 2021Recruiting
9
Effect of Sodium Alendronate on the Final Implant Stability.
Condition(s):Anterior Labial Wall DefectLast Updated:December 17, 2021Recruiting
10
Romosozumab in Women With Chronic SCI
Condition(s):Osteoporosis; Bone Loss; Osteopenia, Osteoporosis; Spinal Cord Injuries; Chronic Spinal ParalysisLast Updated:January 5, 2022Recruiting